Literature DB >> 29460040

Benign and malignant hepatocellular lesions in patients with vascular liver diseases.

Valérie Vilgrain1,2, Valérie Paradis2,3, Morgane Van Wettere1, Dominique Valla2,4, Maxime Ronot5,6, Pierre-Emmanuel Rautou2,4,7.   

Abstract

A variety of vascular liver disorders can induce hepatocellular tumors. They may be related to portal venous deprivation, venous outflow obstruction, or arterial diseases. Their common feature is an imbalance between hepatic arterial and portal venous blood flow leading to an increased hepatic arterial inflow. Consequently, hepatocellular tumors may arise, most commonly focal nodular hyperplasia-like lesions but hepatocellular adenomas and hepatocellular carcinoma may be seen as well. This article will review the most common vascular liver diseases associated with hepatocellular nodules (Budd-Chiari syndrome, congenital portosystemic shunt, hereditary hemorrhagic telangiectasia, and portal cavernoma). For each condition, imaging findings will be described as well as the differential diagnosis and the diagnostic clues.

Entities:  

Keywords:  Budd–Chiari syndrome; Hepatocellular carcinoma; Regenerative nodule; Shunt

Mesh:

Year:  2018        PMID: 29460040     DOI: 10.1007/s00261-018-1502-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

Review 1.  Hepatocellular nodules in vascular liver diseases.

Authors:  Christine Sempoux; Charles Balabaud; Valérie Paradis; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2018-05-26       Impact factor: 4.064

2.  An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration.

Authors:  Hironori Tanaka; Yoshihito Saijo; Tetsu Tomonari; Takahiro Tanaka; Tatsuya Taniguchi; Shusuke Yagi; Koichi Okamoto; Hiroshi Miyamoto; Masahiro Sogabe; Yasushi Sato; Naoki Muguruma; Koichi Tsuneyama; Masataka Sata; Tetsuji Takayama
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

3.  An elderly man with progressive focal nodular hyperplasia.

Authors:  Koichi Hamada; Satoshi Saitoh; Noriyuki Nishino; Daizo Fukushima; Kae Techigawara; Ryota Koyanagi; Yoshinori Horikawa; Yoshiki Shiwa; Hideo Sakuma; Fukuo Kondo
Journal:  Clin J Gastroenterol       Date:  2019-11-25

4.  Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.

Authors:  Morgane Van Wettere; Luisa Paulatto; Lucas Raynaud; Onorina Bruno; Audrey Payancé; Aurélie Plessier; Pierre-Emmanuel Rautou; Valérie Paradis; Dominique Cazals-Hatem; Dominique Valla; Valérie Vilgrain; Maxime Ronot
Journal:  JHEP Rep       Date:  2020-03-09

5.  A rare Abernethy Ib malformation was initially misdiagnosed as chronic portal vein thrombosis in a 27-year-old female.

Authors:  Mehrdad Kayedi; Behnam Kian; Arash Teimouri
Journal:  Radiol Case Rep       Date:  2022-07-28

Review 6.  Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.

Authors:  Riccardo Inchingolo; Alessandro Posa; Martin Mariappan; Tiago Kojun Tibana; Thiago Franchi Nunes; Stavros Spiliopoulos; Elias Brountzos
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.